Skip to Content
Merck
CN

V900279

Sigma-Aldrich

Strontium chloride hexahydrate

Vetec, reagent grade, 99%

Sign Into View Organizational & Contract Pricing

Select a Size


About This Item

Linear Formula:
SrCl2 · 6H2O
CAS Number:
Molecular Weight:
266.62
EC Number:
MDL number:
UNSPSC Code:
12352300
PubChem Substance ID:
Assay:
99%
Grade:
reagent grade
Form:
chunks or granules
crystalline powder
powder or crystals
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

reagent grade

product line

Vetec

Assay

99%

form

chunks or granules
crystalline powder
powder or crystals

mp

115 °C (lit.)

SMILES string

O.O.O.O.O.O.Cl[Sr]Cl

InChI

1S/2ClH.6H2O.Sr/h2*1H;6*1H2;/q;;;;;;;;+2/p-2

InChI key

AMGRXJSJSONEEG-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Corrosion

Signal Word

Danger

Hazard Statements

Precautionary Statements

Hazard Classifications

Eye Dam. 1

Storage Class Code

11 - Combustible Solids

WGK

WGK 1


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bernhard Pemmer et al.
Journal of synchrotron radiation, 18(Pt 6), 835-841 (2011-10-15)
Based on clinical trials showing the efficacy to reduce vertebral and non-vertebral fractures, strontium ranelate (SrR) has been approved in several countries for the treatment of postmenopausal osteoporosis. Hence, it is of special clinical interest to elucidate how the Sr
Salil Vengalil et al.
Current opinion in supportive and palliative care, 6(3), 310-315 (2012-06-20)
Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of
Diane Cummins
American journal of dentistry, 23 Spec No A, 3A-13A (2011-02-03)
To provide a brief overview of the diagnosis, epidemiology, etiology and clinical management of dentin hypersensitivity, to discuss technical approaches to relieve sensitivity, with special emphasis on dentin tubule occlusion and the clinical evidence for efficacy of desensitizing toothpastes based
Serdal Kirmizialtin et al.
Biophysical journal, 102(4), 829-838 (2012-03-06)
The distributions of different cations around A-RNA are computed by Poisson-Boltzmann (PB) equation and replica exchange molecular dynamics (MD). Both the nonlinear PB and size-modified PB theories are considered. The number of ions bound to A-RNA, which can be measured
Karen A Autio et al.
Current treatment options in oncology, 13(2), 174-188 (2012-04-25)
Skeletal metastases threaten quality of life, functionality, and longevity in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapeutic strategies for bone metastases in prostate cancer can palliate pain, delay/prevent skeletal complications, and prolong survival. Pharmacologic agents representing several drug classes

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service